| |  Online-Ressource |
|---|
| Verfasst von: | Giannitsis, Evangelos [VerfasserIn]  |
|---|
| | Blankenberg, Stefan [VerfasserIn] |
|---|
| | Christenson, Robert H. [VerfasserIn] |
|---|
| | Frey, Norbert [VerfasserIn] |
|---|
| | Haehling, Stephan von [VerfasserIn] |
|---|
| | Hamm, Christian [VerfasserIn] |
|---|
| | Inoue, Kenji [VerfasserIn] |
|---|
| | Katus, Hugo [VerfasserIn] |
|---|
| | Lee, Chien-Chang [VerfasserIn] |
|---|
| | McCord, James [VerfasserIn] |
|---|
| | Möckel, Martin [VerfasserIn] |
|---|
| | Chieh, Jack Tan Wei [VerfasserIn] |
|---|
| | Tubaro, Marco [VerfasserIn] |
|---|
| | Wollert, Kai Christoph [VerfasserIn] |
|---|
| | Huber, Kurt [VerfasserIn] |
|---|
| Titel: | Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome |
|---|
| Verf.angabe: | Evangelos Giannitsis, Stefan Blankenberg, Robert H.Christenson, Norbert Frey, Stephan von Haehling, Christian W.Hamm, Kenji Inoue, Hugo A.Katus, Chien-Chang Lee, James McCord, Martin Möckel, Jack Tan Wei Chieh, Marco Tubaro, Kai C.Wollert & Kurt Huber |
|---|
| E-Jahr: | 2021 |
|---|
| Jahr: | 26 February 2021 |
|---|
| Umfang: | 16 S. |
|---|
| Fussnoten: | Gesehen am 24.07.2023 |
|---|
| Titel Quelle: | Enthalten in: Clinical research in cardiology |
|---|
| Ort Quelle: | Berlin : Springer, 2006 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 110(2021), 9, Seite 1353-1368 |
|---|
| ISSN Quelle: | 1861-0692 |
|---|
| Abstract: | Multiple new recommendations have been introduced in the 2020 ESC guidelines for the management of acute coronary syndromes with a focus on diagnosis, prognosis, and management of patients presenting without persistent ST-segment elevation. Most recommendations are supported by high-quality scientific evidence. The guidelines provide solutions to overcome obstacles presumed to complicate a convenient interpretation of troponin results such as age-, or sex-specific cutoffs, and to give practical advice to overcome delays of laboratory reporting. However, in some areas, scientific support is less well documented or even missing, and other areas are covered rather by expert opinion or subjective recommendations. We aim to provide a critical appraisal on several recommendations, mainly related to the diagnostic and prognostic assessment, highlighting the discrepancies between Guideline recommendations and the existing scientific evidence. |
|---|
| DOI: | doi:10.1007/s00392-021-01821-2 |
|---|
| URL: | kostenfrei: Volltext: https://doi.org/10.1007/s00392-021-01821-2 |
|---|
| | kostenfrei: Volltext: https://link.springer.com/10.1007/s00392-021-01821-2 |
|---|
| | DOI: https://doi.org/10.1007/s00392-021-01821-2 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1853486965 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
| |
|
|---|
| | |
|---|
| Lokale URL UB: |  Zum Volltext |
|---|
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome / Giannitsis, Evangelos [VerfasserIn]; 26 February 2021 (Online-Ressource)
